RBC Capital Markets raised its recommendation on KB Home (NYSE:KBH) and Lennar (NYSE:LEN), considering the homebuilders' ...

In recent days, Fed Chair Jerome Powell and other officials have made it clear they're slowing down on lowering rates. Amid ...

Amy Wu Silverman, RBC Capital Markets head of derivatives strategy, joins CNBC's 'Squawk Box' to discuss market outlooks, ...

Exxon Mobil signaled on Tuesday that sharply lower oil refining profits and weakness across all its businesses would reduce ...

For much of last year, Exxon and other oil majors faced reduced profitability from refining crude oil and selling petroleum ...

Exxon Mobil shares fell nearly 2% in early trading on Wednesday after the top U.S. oil producer warned of a decline in ...

Shell, the world's largest LNG trader, said trading results for the division in the fourth quarter would be significantly ...

Find insight on BBVA, Australia’s banks and more in the latest Market Talks covering Financial Services.

RBC Capital analyst Ashish Sabadra maintained a Hold rating on Cboe Global Markets (CBOE – Research Report) on January 6 and set a price target ...

In a report released on January 7, Josh Wolfson from RBC Capital maintained a Hold rating on Newmont Mining (NEM – Research Report), with a ...

A hot jobs report makes it even more likely the Federal Reserve won’t cut rates at its next meeting in January — or for the foreseeable future.

Investing.com -- Shares of Apellis Pharmaceuticals (NASDAQ: APLS) fell 8.9% in premarket trading following news that the FDA accepted a revised supplemental application from competitor Astellas Pharma ...